Abstract: The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologues of these antibodies, humanized and resurfaced versions of these antibodies, functional equivalents and improved versions of these antibodies, immunoconjugates and compositions comprising these antibodies, and the uses of same in diagnostic, research and therapeutic applications. The invention also relates to a polynucleotide encoding these antibodies, vectors comprising the polynucleotides, host cells transformed with polynucleotides and methods of producing these antibodies.

Abstract: A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, its production and its use a medicament, especially for the treatment of allergies.

Abstract: The present invention provides methods and compositions for the treatment, prevention, or reduction of persistent infections, such as chronic infections, latent infections, and slow infections and cancer. The methods and compositions of the invention are also useful for the alleviation of one or more symptoms associated with such infections and cancer.

Abstract: Disclosed herein are glycan-modified anti-CD4 monoclonal antibodies with N-linked glycans attached to the variable region. Expression vectors and cell lines useful for the production of such antibodies, and use of such antibodies for HIV prevention and therapy are also disclosed.

Abstract: The present invention relates to an ICOS binding protein or antigen binding portion thereof that is an agonist to human ICOS and does not induce complement, ADCC, or CDC when placed in contact with a T cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said ICOS binding protein or antigen binding portion thereof. Further the ICOS binding proteins or antigen binding portions thereof of the present invention are capable of activating a T cell when placed in contact with said T cell; stimulating T cell proliferation when placed in contact with said T cell and/or inducing cytokine production when placed in contact with said T cell. The present invention relates to ICOS binding proteins or antigen binding portions thereof comprising one or more of: SEQ ID NO:1; SEQ ID NO:2; SEQ ID NO:3; SEQ ID NO:4; SEQ ID NO:5; and/or SEQ ID NO:6.

Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically hind to PD-L1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The disclosure also provides methods for detecting PD-L1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-L1 antibodies.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: High affinity antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are effective in the inhibition of IL-13R?1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13?1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing IL-13R?1-mediated activities are also disclosed.

Abstract: Disclosed in the present invention is an antibody specifically binding to GLP-1R and a fusion protein thereof with GLP-1. The fusion proteins can effectively bind to a human GLP-1R receptor and activate a receptor signaling pathway, thus are useful for treating diabetes, excessive weight, obesity and related disorders thereof.

Abstract: The present invention relates to VEGF-binding agents, DLL4-binding agents, VEGF/DLL4 bispecific binding agents, and methods of using the agents for treating diseases such as cancer. The present invention provides antibodies that specifically bind human VEGF, antibodies that specifically bind human DLL4, and bispecific antibodies that specifically bind human VEGF and/or human DLL4. The present invention further provides methods of using the agents to inhibit tumor growth. Also described are methods of treating cancer comprising administering a therapeutically effect amount of an agent or antibody of the present invention to a patient having a tumor or cancer.

Abstract: The invention comprises a complex comprising as first part an antibody derived part that specifically binds to a target antigen, and as second part a virus-derived peptide linked to a WIC class I protein complex.

Abstract: Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent using a pharmaceutical composition including at least one recombinant heteromultimeric neutralizing binding protein including two or multiple binding regions, such that the binding regions are not identical, and each binding region specifically binds a non-overlapping portion of the disease agent, thereby treating the subject for exposure to the disease agent. In a related embodiment, the heteromultimeric neutralizing binding protein includes two or multiple binding regions that neutralize a plurality of disease agents. In certain embodiments, the disease agent includes a bacterium, a bacterial protein, a virus, a viral protein, a cancer cell, and a protein or molecule produced therefrom. In certain embodiments, the disease agent is a plurality of different disease agents.

Abstract: Products and processes that are related to phosphonated polysaccharide compositions, including phosphonated polysaccharide gels, having a substituent degree of substitution with a lower limit of 0.02 and an upper limit of 3, and having a weight average molecular weight with an upper limit of 5,000,000 g/mole, as well as to oil field application or fracturing fluid compositions comprising such phosphonated polysaccharide compositions.

Abstract: The present invention concerns the preparation of chemically modified derivatives of chitosan with acrylic groups and their use in the field of enamel-dentin adhesives. Chitosan derivatives have physical-chemical features (hydrophilicity, presence of electrical charges on the chain) which allow them to interact with the organic part of the demineralized tooth. At the same time, the acrylic groups incorporated in the polymer chain allow the formation of a covalent bond with the restorative material used in the dental field that is typically composed of acrylic resins. By combining the adhesion to the tooth surface and the bond with the restorative material, the chemically modified chitosan described herein is able to increase the lifespan of the dental restoration and can thus find use in the field of adhesives, in particular enamel-dentin adhesives.

Abstract: The present invention relates to a modified diene elastomer predominantly comprising a species coupled via a group bearing a function comprising a silicon atom predominantly hydrolysed into silanol and a tertiary amine function, linked to the diene elastomer via the silicon atom, and to the process for synthesizing the modified diene elastomer. This elastomer has the particular feature of not undergoing any change in Mooney viscosity during its storage.

Abstract: There is provided a process for producing an ionomer comprising the steps of (a) admixing in a mixer a halogenated copolymer with at least one nitrogen and/or phosphorus based nucleophile and (b) extruding the mixture from step (a). The process takes place with high conversion and the resulting ionomer contains a low amount of residual nucleophile and has a low yellowness index.

Abstract: Described herein are methods for continuous solution polymerization. The method may comprise polymerizing one or more monomers and comonomers in the presence of a solvent in a polymerization reactor to produce a polymer solution; determining the composition of the polymer solution exiting the polymerization reactor in an on-line fashion; determining at least one of the critical pressure or critical temperature; comparing the critical pressure and/or critical temperature to the actual temperature of the polymer solution and the actual pressure of the polymer solution; heating or cooling the polymer solution to a temperature within 50° C. of the critical temperature; and passing the polymer solution through a pressure letdown valve into a liquid-liquid separator, where the pressure of the polymer solution is reduced or raised to a pressure within 50 psig of the critical pressure to induce a separation of the polymer solution into two liquid phases.

Abstract: In a first aspect, the present invention concerns a kit for a polymerisable composition comprising a portion A constituted by a composition comprising at least one monomer (a1) that is reactive towards a cationic species (b) or a Lewis or Brönsted acid species, and at least one co-initiator, and a portion B comprising at least one cationic salt (e) selected from the salts with formula S1, S3, and S4 shown and defined in claim 1. In a second aspect, the present invention concerns a method of producing a coating or a composite material starting from polymerisable composition comprising at least one salt (e) selected from the salts with formula S1, S2, S3, and S4 shown and defined in claim 10, said composition being polymerised without adding external heat thereto.

Abstract: Described herein is a method of purifying a product and recycling water comprising the following steps: (i) providing a crude product comprising at least one low molecular weight fluoroorganic compounds wherein the low molecular weight fluoroorganic compounds is partially fluorinated and comprises a polar group and/or a reactive group; (ii) extracting the impurity from the product using water to form an extract, (iii) contacting the extract with a radical-forming process to degrade the low molecular weight fluoroorganic compounds into carbon dioxide, water, fluorine ions, and optionally cations; and (iv) using the water from step (iii) in step (ii)

Abstract: This invention relates to a process for forming a long-chain branched polymer and a long-chain branched polymer resulting from the process. The process comprises reacting (a) a polyolefin base polymer with (b) a coupling agent comprising a polymeric coupling agent, optionally blended with a molecular coupling agent, the polymeric coupling agent being a modified polyolefin having a reactive coupling group at one or more terminal ends of the modified polyolefin chain, to couple the polyolefin base polymer (a) with the coupling agent (b) to form a long-chain branched polymer having a long-chain branching and/or higher surface energy relative to the polyolefin base polymer.

Abstract: Catalyst systems and methods for making and using the same. A method of polymerizing olefins to produce a polyolefin polymer with a multimodal composition distribution, includes contacting ethylene and a comonomer with a catalyst system. The catalyst system includes a first catalyst compound and a second catalyst compound that are co-supported to form a commonly supported catalyst system. The first catalyst compound includes a compound with the general formula (C5HaR1b)C5HcR2d)HfX2. The second catalyst compound includes at least one of general formulas (A) or (B). In both catalyst systems, the R groups can be independently selected from any number of substituents, including, for example, H, a hydrocarbyl group, a substituted hydrocarbyl group, or a heteroatom group, among others.

Abstract: A copolymer comprising trans-1,3,3,3-tetrafluoropropene units and vinylidene fluoride units, and methods of making the same. A method of preventing biofouling on an article of manufacture, comprising applying such copolymer to the article of manufacture. A process of preparing a surface having a surface energy of between about 20 and about 30 mJ/m2, comprising applying such a copolymer to a support. A method of preventing accumulation of ice on an article of manufacture, comprising applying such a copolymer to an article of manufacture. A method of preparing a polymer, comprising a step of adding trans-1,3,3,3-tetrafluoropropene/vinylidene fluoride copolymer as a polymer processing additive/aid to said polymer.

Abstract: The present invention pertains to a process for the manufacture of a crosslinkable fluoropolymer, to said crosslinkable fluoropolymer and the crosslinked fluoropolymer obtainable therefrom, to a film comprising said crosslinkable fluoropolymer or said crosslinked fluoropolymer and to uses of said crosslinked fluoropolymer film in various applications.

Abstract: A film layer comprising a high-chi (?) block copolymer for self-assembly and a surface active polymer (SAP) was prepared on a substrate surface that was neutral wetting to the domains of the self-assembled block copolymer. The block copolymer comprises at least one polycarbonate block and at least one other block (e.g., a styrene-based block). The SAP comprises a hydrophobic fluorinated first repeat unit and a non-fluorinated second repeat unit bearing at least one pendent OH group present as an alcohol or acid (e.g., carboxylic acid). The film layer, whose top surface has contact with an atmosphere, self-assembles to form a lamellar or cylindrical domain pattern having perpendicular orientation with respect to the underlying surface. Other morphologies (e.g., islands and holes of height 1.0Lo) were obtained with films lacking the SAP. The SAP is preferentially miscible with, and lowers the surface energy of, the domain comprising the polycarbonate block.

Abstract: Embodiments of the present technology include a formaldehyde-free binder composition. The composition may include melamine. The composition may also include a reducing sugar. In addition, the binder composition may include a non-carbohydrate aldehyde or ketone. Embodiments may also include a method of making a formaldehyde-free binder composition. The method may include dissolving melamine in an aqueous solution of a reducing sugar. The concentration of the reducing sugar may be 30 wt. % to 70 wt. % of the aqueous solution, which may be at a temperature of 50° C. to 100° C. The method may also include adding a non-carbohydrate aldehyde or ketone to the dissolved melamine in the aqueous solution to form a binder solution. The temperature of the aqueous solution of the dissolved melamine may be 50° C. to 100° C. during the addition of the non-carbohydrate aldehyde or ketone. The method may further include reducing the temperature of the binder solution.

Abstract: A curable aqueous polyurethane dispersion is formed by reacting a polyol a) component with a polyisocyanate b) in excess to form a polyurethane pre-polymer which is neutralized and dispersed before chain extending with a chain extender c) to form the final polyurethane polymer aqueous dispersion. The polyol a) component comprises a1) at least one non-ionic polyol, a 2) at least one polyol bearing at least one ionic or potentially ionic group comprising an acid group or salt thereof and a3) at least one ethylenically unsaturated monoalcohol or polyol. The polyol component contains carbon atoms from renewable resources. A method for making the curable aqueous polyurethane dispersion, uses of the aqueous polyurethane dispersion, cured polyurethanes are also disclosed.

Abstract: A two-component polyurethane composition with a viscosity of 20 to 3000 mPa·s (EN ISO 2555, 25° C.), containing i) 10 to 80 wt. % of at least one polyol with a number-average molecular weight of 200 g/mol to 3000 g/mol, ii) 5 to 70 wt. % of at least one polyisocyanate, iii) 0 to 10 wt. % of a catalyst, wherein the composition has an NCO:OH ratio of 2:1 to 1:2 and polyisocyanates are used, wherein 3 to 25 mol % of the NCO groups of the polyisocyanate are converted into carbodiimide and/or uretonimine. The two-component polyurethane compositions are used as matrix binders for fiber composite moldings.

Abstract: Described herein are heterocyclic organic compounds. More specifically, described herein are compounds based on the combination of fused pyrrole structures with diketopyrrolopyrrole structures, methods for making these compounds, and uses thereof. The compounds disclosed have improved electronic, polymerization and stability properties that allow for improved material processability and inclusion in organic semiconductor devices.

Abstract: The invention relates to a method for producing polyether ester carbonate polyols by attaching at least one alkylene oxide, at least one cyclical anhydride, and carbon dioxide to one or more H-functional starter substances in the presence of a double metal cyanide catalyst. The method is characterized in that (?) a suspension agent, which does not contain H-functional groups, is provided in a reactor, and (?) one or more H-functional starter substances are continuously metered into the reactor during the reaction process, and the one or more alkylene oxides, the cyclical anhydride, and optionally the carbon dioxide are metered simultaneously or sequentially.

Abstract: This invention relates to novel polymer polyols, to a process for preparing these novel polymer polyols, to flexible polyurethane foams comprising these novel polymer polyols, and to a process for the production of these flexible polyurethane foams. These novel polymer polyols provide unexpected improvements in foams prepared therefrom.

Abstract: Hexahydrotriazine (HT) materials and hemiaminal (HA) materials derived from aromatic, aliphatic, and/or polyether diamines may be used as a platform for creating flame retardant materials. Various flame retardant material precursors may be incorporated into the HA and HT materials. Examples of flame retardant precursors may include organohalogen materials, organophosphorous materials, melamines, and dianiline compounds, among others. The flame retardant materials and precursors may be single molecule species, oligomers, and/or polymers (i.e., polyhexahydrotriazine, PHT, polyhemiaminal, PHA). The flame retardant materials may be made using an aromatic diamine, an aliphatic diamine, a polyether diamine, or a mixture thereof to react with an aldehyde (i.e. formaldehyde or paraformaldehyde). Such flame retardant material precursors will complex with the diamine monomers via a copolymerization reaction to form the flame retardant materials.

Abstract: A copolymer composition is provided that is formed as the reaction product of (I) a cured polyorganosiloxane intermediate having repeating Si—O—Si units and at least one Si—OH functional group and (II) a polyfluoropolyether silane. The cured polyorganosiloxane intermediate has a surface having a water contact angle ranging from 40° to 90° as measured by ASTM 5946-04. In certain embodiments, the copolymer composition provides improved dust resistance as compared with cured polyorganosiloxanes from which the copolymer composition is formed.

Abstract: A number of new classes of polymers with the potential for electrical conduction are introduced sharing a common theme, having metal atoms in direct contact with each other, bound in one and two-dimensional structures guided by steric, dipole and coordinating ligand factors. These new classes include a new family of metallole polymers in a polycyclic arrangement, for use both standing alone, and with chains of metal atoms coordinated to their electronegative backbone atoms, new polymers of group 13 and 14 metals and metalloids, with substituents connected through an electronegative bonding atom, and a new class of close stacked porphyrin polymers, assembled with short molecular linkers perpendicular to the faces of the porphyrin units. These new materials empower new classes of capacitors, batteries and electrical conductors, even superconductors.

Abstract: Provided herein is a process of preparing a semi-random graft co-polymer, the product of which is difficult to fully characterize chemically. The product of the present disclosure has unique and useful properties of 1) binding to a peptide and 2) upon co-administration of the product and the peptide into animals the product prolongs the blood circulation time and elevates the level of the peptide, compared to the peptide alone without the product of the disclosure.

Abstract: A polyarylene sulfide resin powder/grain composition in which 100 weight parts of polyarylene sulfide resin powder/grain material whose average particle diameter exceeds 1 ?m and is less than or equal to 100 ?m and whose uniformity degree is less than or equal to 4 has been blended with 0.1 to 5 weight parts of an inorganic fine particle having an average particle diameter greater than or equal to 20 nm and less than or equal to 500 nm.

Abstract: A masterbatch composition of elastomer and from 20 to 100 parts per hundred parts elastomer of fibrous micropulp wherein the micropulp has fibers with a volume weighted average fiber length of from 20 to 200 micrometers as measured by laser diffraction, a relative specific surface area of from 30 to 600 square meter per gram as measured by nuclear magnetic resonance and the fibers selected from the group consisting of aromatic polyamide, aromatic copolyamide, polyacrylonitrile and polyazole.

Abstract: An ion exchange membrane obtained by using an ionic monomer having at least two or more polymerizable functional groups, in which a hydrophobicity index H obtained by an expression below from a monomer for forming an ion exchange resin and a material fixed to the resin in the ion exchange membrane is 1.6 or greater, and a manufacturing method therefor.

Abstract: Disclosed is a circuit material, including dielectric substrate or a circuit subassembly further comprising a conductive layer, that is formed from a precursor composition, wherein the precursor composition comprises, based on the total weight of the precursor composition, thermosetting resin or thermoplastic polymer, optionally monomeric triallyl isocyanurate or triallyl cyanurate, dispersed particles of poly(triallyl isocyanurate) or poly(triallyl cyanurate), and optionally inorganic filler, wherein the circuit material has a Df of less than 0.0060 at 10 GHz. Also disclosed is a method of manufacturing such a circuit material in which emulsion polymerized particles of poly(triallyl isocyanurate) or poly(triallyl cyanurate) are dispersed in a thermosetting or thermoplastic resin.

Abstract: Uncured epoxy resin for use in making prepreg for aerospace applications. The resin includes an epoxy resin component comprising difunctional epoxy resin, trifunctional epoxy resin and/or tetrafunctional epoxy resin and a sufficient amount of [3-(4-aminobenzoyl) oxyphenyl] 4-aminobenzoate (3-ABOAB), as a curing agent, such that the uncured resin can be stored at room temperature of at least 6 weeks and wherein the uncured resin can be fully cured in no more than 2 hours at a temperature of between 175° C. and 185° C.

Abstract: A formulation includes a polymeric material, a nucleating agent, a blowing, and a surface active agent. The formulation can be used to form a container.

Abstract: The present invention relates to exterior siding, trim and rigid architectural assemblies for buildings.

Abstract: A blowing agent for thermosetting foams is disclosed. The blowing agent is a hydrofluoroolefin (HCFO), preferably HFCO-1234ze in combination with a hydrochlorofluoroolefin (HCFO) preferably one selected from HCFO-1233zd, HCFO-1223, HCFO-1233xf and mixtures thereof. The blowing agent is effective as a blowing agent in the manufacture of thermosetting foams.

Abstract: A process for the production of crosslinked PVC foams includes the preparation of a polymeric mixture based on PVC, isocyanate, anhydride, nucleating agent and a physical blowing agent, heating this mixture in a reaction mold, cooling the polymeric mass thus obtained, opening the mold in order to extract the microcellular embryo, and expanding and completing the crosslinking reactions of the embryo in an oven.

Abstract: A resin composite in which a fiber-reinforced resin material comprising fibers and a resin, and a resin expanded body are integrally laminated, wherein the resin expanded body has a hole opened at the interface with the fiber-reinforced resin material and resin of the fiber-reinforced resin material is caused to flow into the hole.

Abstract: A method is provided for de-bonding objects contained in an article at an interface between the objects, wherein the objects are joined at the interface through an intermediate layer, which involves applying energy from a radiation source, wherein the energy is sufficient to cause destruction of bonds within the intermediate layer; and separating the two objects from one another.

Abstract: A composition, which comprises a) an organic material susceptible to oxidative, thermal or light-induced degradation; and b) a compound of formula I (Formula I) (I) where R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are independently from each other H, C1-C8-alkyl, C4-C8-cycloalkyl, phenyl, C1-C4-alkoxy or halogen; n is 1, 2, 3, or 4; and when n is 1 A is —C(=0)-OR?1, —C(=0)-N(R?2)(R?3), —CN, phenyl, which is unsubstituted or substituted by one or more C1-C8-alkyl, C4-C8-alkoxy, C5-C7-cycloalkyl or halogen, —H or —S02-phenyl; when n is 2 A is —C(=0)-0-Z1—O—C(=0)-, —C(=0)-N(R?1)—Z2—N(R?2)—C(=0)- or piperazine-N,N?-biscarbonyl.

Abstract: A Mannich Base curing agent is provided that is prepared by reacting acetone, a phenolic compound and a primary amine. These curing agents are useful as sole curing agents and as co-curing agents for epoxy resin systems. The invention also includes a curable composition having an epoxy resin having at least 1.5 epoxy groups per molecule; and a Mannich Base prepared by reacting (i) a ketone (ii) a phenolic compound and (iii) a primary aliphatic or cycloaliphatic polyamine in which the Mannich Base has a viscosity of less than 500 cP at 25° C.

Abstract: In an embodiment, a method for making a thermoplastic composition, comprising: melt polymerizing a polycarbonate, extruding and melt filtering the polycarbonate to form a melt filtered polycarbonate; forming the thermoplastic composition comprising the melt filtered polycarbonate, 0.03 to 0.05 wt % of a triacylglyceride release agent; and 0.10 to 0.14 wt % of a UV stabilizer; wherein the weight percentages are based on the total weight of the composition; and extruding the thermoplastic composition.

Abstract: A process directed to emulsion polymerization (EP) methods for producing seed particles reproducibly independent of initiator amount and rate of introduction.

Abstract: An object of the present invention is to provide an antistatic agent composed of a donor-acceptor type molecular compound that can prevent static charge on an insulating polymer material surely with good persistency and reproducibility. The antistatic agent of the present invention is an antistatic agent for an insulating polymer material composed of a donor-acceptor type molecular compound represented by the general formula (1) below and obtained by mixing, melting and reacting a semi-polar organoboron compound (donor component) of the upper part in the general formula (1) below with a basic nitrogen compound (acceptor component) of the lower part in the general formula (1) below, wherein R1 and R2 are each independently CH3(CH2)16—CO—OCH2 or HOCH2 and at least one thereof is CH3(CH2)16—CO—OCH2; R3 and R4 are each independently CH3, C2H5, HOCH2, HOC2H4, or HOCH2CH(CH3); and R5 is C2H4 or C3H6.